A Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenstr öm's Macroglobulinemia
Condition: Waldenström's Macroglobulinemia Intervention: Drug: zanubrutinib,bendamustine,rituximab Sponsors: Shanghai Changzheng Hospital; RenJi Hospital; Huashan Hospital; Shanghai 6th People's Hospital; Huadong Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Clinical Trials | Hospitals | Macroglobulinemia | Research | Rituxan | Treanda | Waldenstrom's Macroglobulinemia